Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7070 in Metastatic Melanoma
NCT00014625Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Feb 2001
- Primary completion
- Nov 2001
- Modality
- RNA-Targeting Small Molecules, Molecular Glues
- Countries
- 9
01
Overview
Phase 2, open-label, single-arm trial of indisulam in melanoma, sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoints: Objective Response, Duration of Response and 1 more. Started Feb 2001; status: completed.
02
Drugs
indisulam
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00014625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014625.